• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Efficacy and Safety of WCFA19 ( WIKIM51) in Reducing Body Fat in Overweight and Obese Adults.WCFA19(WIKIM51)对超重和肥胖成年人减少体脂的疗效及安全性
J Clin Med. 2024 Apr 26;13(9):2559. doi: 10.3390/jcm13092559.
2
Effect of MED-02 Containing Two Probiotic Strains, MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.含两种益生菌菌株 MG4231 和 MG4244 的 MED-02 对超重或肥胖受试者体脂减少的影响:一项随机、多中心、双盲、安慰剂对照研究。
Nutrients. 2022 Aug 30;14(17):3583. doi: 10.3390/nu14173583.
3
Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial.Sinetrol-XPur 在超重或肥胖成年人减轻体重和体脂肪方面的功效和安全性:一项为期 12 周、随机、双盲、平行、安慰剂对照试验。
J Med Food. 2020 Mar;23(3):335-342. doi: 10.1089/jmf.2019.4649. Epub 2020 Mar 4.
4
Effect of a Multispecies Synbiotic Supplementation on Body Composition, Antioxidant Status, and Gut Microbiomes in Overweight and Obese Subjects: A Randomized, Double-Blind, Placebo-Controlled Study.多菌种合生制剂补充对超重和肥胖受试者体成分、抗氧化状态和肠道微生物组的影响:一项随机、双盲、安慰剂对照研究。
Nutrients. 2023 Apr 13;15(8):1863. doi: 10.3390/nu15081863.
5
Efficacy and safety of HT048 and HT077 for body fat and weight loss in overweight adults: A study protocol for a double-blind, randomized, placebo-controlled trial.HT048和HT077对超重成年人身体脂肪和体重减轻的疗效与安全性:一项双盲、随机、安慰剂对照试验的研究方案
Medicine (Baltimore). 2019 Nov;98(45):e17922. doi: 10.1097/MD.0000000000017922.
6
Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet.益生菌酸奶对有或没有减肥饮食的超重和肥胖人群外周血单核细胞中脂肪分布及促炎因子基因表达的影响
J Am Coll Nutr. 2014;33(6):417-25. doi: 10.1080/07315724.2013.874937. Epub 2014 Jul 31.
7
Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.超重和肥胖受试者中黑大豆肽补充剂的减肥效果:双盲、随机、对照研究。
Food Funct. 2012 Oct;3(10):1019-24. doi: 10.1039/c2fo10244g. Epub 2012 Jun 28.
8
Effect of Lactobacillus sakei, a Probiotic Derived from Kimchi, on Body Fat in Koreans with Obesity: A Randomized Controlled Study.泡菜益生菌发酵短乳杆菌对韩国肥胖人群体脂的影响:一项随机对照研究。
Endocrinol Metab (Seoul). 2020 Jun;35(2):425-434. doi: 10.3803/EnM.2020.35.2.425. Epub 2020 Jun 24.
9
Anti-obesity effect of kimchi fermented with Weissella koreensis OK1-6 as starter in high-fat diet-induced obese C57BL/6J mice.以魏斯氏菌科乳酸菌 OK1-6 为发酵剂的泡菜对高脂饮食诱导肥胖 C57BL/6J 小鼠的减肥作用。
J Appl Microbiol. 2012 Dec;113(6):1507-16. doi: 10.1111/jam.12017. Epub 2012 Oct 9.
10
Effect of multi-strain probiotic (UB0316) in weight management in overweight/obese adults: a 12-week double blind, randomised, placebo-controlled study.多菌株益生菌(UB0316)在超重/肥胖成年人体重管理中的作用:一项为期 12 周的双盲、随机、安慰剂对照研究。
Benef Microbes. 2019 Dec 9;10(8):855-866. doi: 10.3920/BM2019.0052. Epub 2019 Dec 4.

引用本文的文献

1
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LMT1-48 on Body Fat Loss.一项为期12周的随机双盲安慰剂对照研究,旨在评估LMT1-48对身体脂肪减少的疗效和安全性。
Nutrients. 2025 Mar 28;17(7):1191. doi: 10.3390/nu17071191.

本文引用的文献

1
The Possible Role of Probiotic Supplementation in Inflammation: A Narrative Review.补充益生菌在炎症中的潜在作用:一项叙述性综述。
Microorganisms. 2023 Aug 26;11(9):2160. doi: 10.3390/microorganisms11092160.
2
Randomized controlled trials reporting the effects of probiotics in individuals with overweight and obesity: A critical review of the interventions and body adiposity parameters.随机对照试验报告超重和肥胖个体中益生菌的作用:对干预措施和体脂参数的批判性评价。
Clin Nutr. 2023 Jun;42(6):835-847. doi: 10.1016/j.clnu.2023.03.017. Epub 2023 Apr 5.
3
Effect of MED-02 Containing Two Probiotic Strains, MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study.含两种益生菌菌株 MG4231 和 MG4244 的 MED-02 对超重或肥胖受试者体脂减少的影响:一项随机、多中心、双盲、安慰剂对照研究。
Nutrients. 2022 Aug 30;14(17):3583. doi: 10.3390/nu14173583.
4
Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial.植物乳杆菌 LMT1-48 对超重受试者体脂的影响:一项随机、双盲、安慰剂对照试验。
Diabetes Metab J. 2023 Jan;47(1):92-103. doi: 10.4093/dmj.2021.0370. Epub 2022 Apr 29.
5
Gut microbiota in obesity.肥胖症中的肠道微生物群。
World J Gastroenterol. 2021 Jul 7;27(25):3837-3850. doi: 10.3748/wjg.v27.i25.3837.
6
SMFM2017-NK4 Isolated from Kimchi Can Prevent Obesity by Inhibiting Fat Accumulation.从泡菜中分离出的SMFM2017-NK4可通过抑制脂肪堆积预防肥胖。
Foods. 2021 Apr 4;10(4):772. doi: 10.3390/foods10040772.
7
Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials.益生菌用于治疗人类超重和肥胖——临床试验综述
Microorganisms. 2020 Jul 29;8(8):1148. doi: 10.3390/microorganisms8081148.
8
Role of jeotgal, a Korean traditional fermented fish sauce, in microbial dynamics and metabolite profiles during kimchi fermentation.韩国传统发酵鱼露在泡菜发酵过程中微生物动态和代谢物特征中的作用。
Food Chem. 2018 Nov 1;265:135-143. doi: 10.1016/j.foodchem.2018.05.093. Epub 2018 May 22.
9
Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.补充加氏乳杆菌BNR17可减少肥胖成年人的内脏脂肪堆积和腰围:一项随机、双盲、安慰剂对照试验。
J Med Food. 2018 May;21(5):454-461. doi: 10.1089/jmf.2017.3937. Epub 2018 Apr 24.
10
The human gut microbiota: Metabolism and perspective in obesity.人类肠道微生物群:肥胖症中的代谢和前景。
Gut Microbes. 2018 Jul 4;9(4):308-325. doi: 10.1080/19490976.2018.1465157. Epub 2018 May 24.

WCFA19(WIKIM51)对超重和肥胖成年人减少体脂的疗效及安全性

Efficacy and Safety of WCFA19 ( WIKIM51) in Reducing Body Fat in Overweight and Obese Adults.

作者信息

Sun Hwayeon, Shin Jinyoung, Kim Min-Ji, Bae Sunghwan, Lee Nicole Dain, Yoo Byungwook

机构信息

Department of Family Medicine, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea.

Department of Family Medicine, Konkuk University Medical Center, Seoul 05030, Republic of Korea.

出版信息

J Clin Med. 2024 Apr 26;13(9):2559. doi: 10.3390/jcm13092559.

DOI:10.3390/jcm13092559
PMID:38731087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11084377/
Abstract

: WCFA19 ( WIKIM51), found during the fermentation of kimchi, is known for its inhibitory effects on body weight and body fat. This study looked at the impact of WCFA19 isolated from dandelion kimchi on weight loss in overweight and obese adults that are otherwise healthy. : This study was conducted as a multicenter, double-blind, randomized, placebo-controlled study with 104 overweight and obese subjects. Subjects were randomized evenly into the test group (WCFA19, 500 mg, = 40) or control group ( = 34) for 12 weeks from 14 June 2021 to 24 December 2021. Effects were based on DEXA to measure changes in body fat mass and percentage. : Among the 74 subjects analyzed, WCFA19 oral supplementation for 12 weeks resulted in a significant decrease in body fat mass of 633.38 ± 1396.17 g ( = 0.0066) in overweight and obese individuals in the experimental group. The control group showed an increase of 59.10 ± 1120.57 g ( = 0.7604), indicating a statistically significant difference between the two groups. There was also a statistically significant difference ( = 0.0448) in the change in body fat percentage, with a decrease of 0.41 ± 1.22% ( = 0.0424) in the experimental group and an increase of 0.17 ± 1.21% ( = 0.4078) in the control group. No significant adverse events were reported. : Oral supplementation of 500 mg of WCFA19 for 12 weeks is associated with a decrease in body weight, particularly in body fat mass and percentage.

摘要

WCFA19(WIKIM51)是在泡菜发酵过程中发现的,以其对体重和体脂的抑制作用而闻名。本研究观察了从蒲公英泡菜中分离出的WCFA19对其他方面健康的超重和肥胖成年人减肥的影响。本研究作为一项多中心、双盲、随机、安慰剂对照研究,共有104名超重和肥胖受试者参与。从2021年6月14日至2021年12月24日,受试者被平均随机分为试验组(WCFA19,500毫克,n = 40)或对照组(n = 34),为期12周。效果基于双能X线吸收法(DEXA)来测量体脂质量和百分比的变化。在分析的74名受试者中,试验组超重和肥胖个体口服WCFA19 12周后,体脂质量显著减少633.38±1396.17克(P = 0.0066)。对照组增加了59.10±1120.57克(P = 0.7604),表明两组之间存在统计学显著差异。体脂百分比的变化也存在统计学显著差异(P = 0.0448),试验组下降了0.41±1.22%(P = 0.0424),对照组增加了0.17±1.21%(P = 0.4078)。未报告重大不良事件。口服500毫克WCFA19 12周与体重下降有关,尤其是体脂质量和百分比。